AccuStem Sciences is a life sciences company dedicated to optimizing outcomes for all patients with cancer.
AccuStem Sciences has raised $2.7M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2022.
AccuStem Sciences's investors include Tiziana Life Sciences.
AccuStem Sciences is headquartered in London, United Kingdom.
AccuStem Sciences is a life sciences company dedicated to optimizing outcomes for all patients with cancer.
AccuStem Sciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AccuStem Sciences — Funding & Investors." VCBacked, April 5, 2022, https://www.vcbacked.co/company/accustem-sciences. Accessed August 13, 2026.
VCBacked. (2022). AccuStem Sciences — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/accustem-sciences
{{cite web |title=AccuStem Sciences — Funding & Investors |url=https://www.vcbacked.co/company/accustem-sciences |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated